Atlas Trials

Mass Balance Study of MT-1303

Clinical trial NCT02293967 · COMPLETED

Trial details

NCT number
NCT02293967
Sponsor
Tanabe Pharma Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsing-remitting Multiple Sclerosis
Start date
2014-09-01
Primary completion
2014-12-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.